...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
【24h】

Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.

机译:对HIV-1逆转录酶抑制剂的虚拟筛选研究,以设计有效的潜在客户。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study is to identify novel and potent inhibitors against HIV-1 reverse transcriptase (RT). The crystal structure of the most active ligand was converted into a feature-shaped query. This query was used to align molecules to generate statistically valid 3D-QSAR (r(2) = 0.873) and Pharmacophore models (HypoGen). The best HypoGen model consists of three Pharmacophore features (one hydrogen bond acceptor, one hydrophobic aliphatic and one ring aromatic) and further validated using known RT inhibitors. The designed novel inhibitors are further subjected to docking studies to reduce the number of false positives. We have identified and proposed some novel and potential lead molecules as reverse transcriptase inhibitors using analog and structure based studies.
机译:这项研究的目的是确定针对HIV-1逆转录酶(RT)的新型有效抑制剂。活性最高的配体的晶体结构被转换为特征形状的查询。此查询用于对齐分子以生成统计上有效的3D-QSAR(r(2)= 0.873)和Pharmacophore模型(HypoGen)。最佳的HypoGen模型包含三个Pharmacophore功能(一个氢键受体,一个疏水性脂族和一个环芳族),并使用已知的RT抑制剂进一步验证。设计的新型抑制剂将进一步进行对接研究,以减少假阳性的数量。我们已经使用基于类似物和结构的研究方法鉴定并提出了一些新颖的和潜在的先导分子作为逆转录酶抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号